Nomura issues ‘Buy’ calls on IndusInd Bank, Voltas, and Sun Pharma with up to 28% upside—read the full analysis to spot your next investment!

The People’s Bank of China held the 1-year loan prime rate at 3.0% and 5-year LPR at 3.5%, according to a statement Friday.

Japanese officials are dismissing alarm over the prediction of a July “catastrophe” in a comic book, “The Future I Saw,” ...

This summer's unseasonal rains caused a 20-25% decline in Voltas's air conditioner sales. Despite some recovery in June, weak ...

Japan’s finance ministry is considering trimming its issuance of super-long bonds starting in July, according to a draft of a revised bond issuance plan seen by Bloomberg.

India's gain from Modi’s latest G7 outing explained, is the oil industry in a crisis, will cement prices rebound after FY25 ...

Tokyo stocks snapped a three-day winning streak Thursday, as concerns grew over intensifying tensions in the Middle East ...

IndusInd Bank's stock witnessed a significant rise. This followed an upgrade by Nomura from 'Neutral' to 'Buy'. The upgrade ...

Nomura upgrades IndusInd Bank to 'Buy' with a revised target price of Rs 1,050, citing improved governance, cleaned-up books, ...

Find insight on Posco Holdings, Canadian steel and aluminum producers and more in the latest Market Talks covering basic ...

Indirect macro effects from weaker US consumer demand and a strong Taiwan dollar will likely be tempered by sustained AI-led ...

IndusInd Bank's shares rose by nearly 6% after global brokerage firm Nomura upgraded its rating on the stock to buy and increased the target price.